Moderna (MRNA) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Moderna Revenue Highlights


Latest Revenue (Y)

$6.85B

Latest Revenue (Q)

$241.00M

Main Segment (Y)

Product Sales

Main Geography (Y)

Rest Of The World

Moderna Revenue by Period


Moderna Revenue by Year

DateRevenueChange
2023-12-31$6.85B-64.45%
2022-12-31$19.26B8.61%
2021-12-31$17.74B6361.44%
2020-12-31$274.49M471.43%
2019-12-31$48.04M-60.79%
2018-12-31$122.51M-30.77%
2017-12-31$176.97M74.30%
2016-12-31$101.54M-

Moderna generated $6.85B in revenue during NA 2023, up -64.45% compared to the previous quarter, and up 5589.66% compared to the same period a year ago.

Moderna Revenue by Quarter

DateRevenueChange
2024-06-30$241.00M44.31%
2024-03-31$167.00M-94.06%
2023-12-31$2.81B53.63%
2023-09-30$1.83B432.27%
2023-06-30$344.00M-81.53%
2023-03-31$1.86B-63.38%
2022-12-31$5.08B57.89%
2022-09-30$3.22B-29.48%
2022-06-30$4.57B-23.13%
2022-03-31$5.94B-14.52%
2021-12-31$6.95B43.90%
2021-09-30$4.83B14.57%
2021-06-30$4.21B141.82%
2021-03-31$1.74B659.89%
2020-12-31$229.38M1777.66%
2020-09-30$12.22M-57.05%
2020-06-30$28.44M538.14%
2020-03-31$4.46M-57.77%
2019-12-31$10.55M-20.88%
2019-09-30$13.34M32.98%
2019-06-30$10.03M-28.94%
2019-03-31$14.12M-56.99%
2018-12-31$32.82M-10.49%
2018-09-30$36.66M41.93%
2018-06-30$25.83M-5.93%
2018-03-31$27.46M-68.94%
2017-12-31$88.42M-

Moderna generated $241.00M in revenue during Q2 2024, up 44.31% compared to the previous quarter, and up 12.94% compared to the same period a year ago.

Moderna Revenue Breakdown


Moderna Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Grant$94.00M$388.00M$735.00M$528.90M$12.17M
Collaboration Arrangement$31.00M$440.00M$61.00M$74.62M-
Product Sales$8.20B$3.88B---
Collaboration Arrangement Including Arrangements With Affiliate---$327.70M-
Collaborative Arrangement With Related Party----$5.23M

Moderna's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Sales (98.50%), Grant (1.13%), and Collaboration Arrangement (0.37%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Product Sales$645.00M$522.00M$3.58B$2.42B$1.00B$1.20B--------------
Grant$20.00M-$50.00M$44.00M$-65.00M$144.00M$183.00M$126.00M$262.00M$140.00M$139.00M$194.00M$341.37M$3.93M$3.50M$3.71M----
Collaboration Arrangement$6.00M$3.00M$12.00M$19.00M$290.00M$100.00M$35.00M$15.00M$14.00M$19.00M$18.00M$10.00M$29.50M$10.05M------
Collaboration Arrangement Including Arrangements With Affiliate--------------$29.50M-----
Collaboration Arrangement, Including Arrangements With Affiliate---------------$366.70M$249.90M$4.46M--
Collaborative Arrangement With Related Party-----------------$1.27M--
Collaborative Arrangement With Affiliate-------------------$3.72M

Moderna's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product Sales (96.13%), Grant (2.98%), and Collaboration Arrangement (0.89%).

Moderna Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20
Rest Of The World$3.60B---
Europe$1.35B$6.73B$6.83B-
UNITED STATES$1.90B$4.41B$5.39B$193.63M
Rest Of World-$7.30B$5.45B-
Non-US---$6.24M

Moderna's latest annual revenue breakdown by geography, as of Dec 23: Rest Of The World (52.54%), UNITED STATES (27.67%), and Europe (19.79%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
UNITED STATES$162.00M$100.00M$979.00M$913.00M$2.00M$1.00M$1.02B$985.00M$1.45B$945.00M$745.00M$1.20B$2.09B$1.36B
Rest Of The World$22.00M$67.00M$1.38B$741.00M$231.00M$1.25B$1.09B$1.69B$2.90B-----
Europe--$616.00M$103.00M$60.00M$576.00M$2.22B$1.04B$1.39B$2.08B----
Non-US-----------$3.61B$2.10B$375.00M

Moderna's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (88.04%), and Rest Of The World (11.96%).

Moderna Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
VRTXVertex Pharmaceuticals$9.84B$2.65B
MRNAModerna$6.85B$241.00M
NVAXNovavax$983.71M$93.86M
BEAMBeam Therapeutics$377.71M$11.77M
DNAGinkgo Bioworks$251.46M$56.21M
CVACCureVac$52.70M$12.37M
KRYSKrystal Biotech$50.70M$83.84M
NTLAIntellia Therapeutics$36.27M$6.96M
EDITEditas Medicine-$513.00K
CWBRCohBar--
AVROAVROBIO--
ELEVElevation Oncology--
OCEAOcean Biomedical--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--

MRNA Revenue FAQ


Moderna's yearly revenue for 2023 was $6.85B, representing a decrease of -64.45% compared to 2022. The company's yearly revenue for 2022 was $19.26B, representing an increase of 8.61% compared to 2021. MRNA's yearly revenue for 2021 was $17.74B, representing an increase of 6361.44% compared to 2020.

Moderna's quarterly revenue for Q2 2024 was $241M, a 44.31% increase from the previous quarter (Q1 2024), and a -29.94% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $167M, a -94.06% decrease from the previous quarter (Q4 2023), and a -91.03% decrease year-over-year (Q1 2023). MRNA's quarterly revenue for Q4 2023 was $2.81B, a 53.63% increase from the previous quarter (Q3 2023), and a -44.67% decrease year-over-year (Q4 2022).

Moderna's revenue growth rate for the last 3 years (2021-2023) was -61.39%, and for the last 5 years (2019-2023) was 14155.97%.

Moderna's revenue streams in c 23 are Grant, Collaboration Arrangement, and Product Sales. Grant generated $94M in revenue, accounting 1.13% of the company's total revenue, down -75.77% year-over-year. Collaboration Arrangement generated $31M in revenue, accounting 0.37% of the company's total revenue, down -92.95% year-over-year. Product Sales generated $8.2B in revenue, accounting 98.50% of the company's total revenue, up 111.35% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Moderna was Product Sales. This segment made a revenue of $8.2B, representing 98.50% of the company's total revenue.